IDEAYA Biosciences, Inc. Common Stock (IDYA) is a publicly traded Healthcare sector company. As of July 17, 2026, IDYA trades at $36.36 with a market cap of $3.54B and a P/E ratio of -22.81. IDYA moved +0.97% today. Year to date, IDYA is +3.93%; over the trailing twelve months it is +62.21%. Its 52-week range spans $13.45 to $40.58. Analyst consensus is strong buy with an average price target of $54.55. Rallies surfaces IDYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for IDYA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $36.36 |
| Market Cap | $3.54B |
| P/E Ratio | -22.81 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.58 |
| 52-Week Low | $13.45 |
| Volume | 498.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $225.27M |
| Net Income | $-140.06M |
| Gross Margin | 0.00% |
12 analysts cover IDYA: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $54.55.